GSK PLC closed 14.69% below its 52-week high of £17.67, which the company reached on May 31st.

This Abrysvo or Arexvy market report delivers an in-depth analysis of the market's key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the ...

GSK PLC closed 18.99% short of its 52-week high of £17.88, which the company achieved on May 28th.

The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...

Semiconductor EDA Software Market is Segmented by Type (Electronic Circuit Design and Simulation, PCB Design, IC Design), by Application (Automotive, Industrial, Consumer Electronics, Communication, ...

GlaxoSmithKline Pharmaceuticals (GSK Pharma) on Friday informed the stock exchanges that a fire had occurred at one of its contract manufacturing facilities, causing a temporary disruption in ...

During today's trading session, the NIFTY MIDCAP 150 saw several stocks decline, with Global Health, JSW Infra, and GlaxoSmithKline leading the losses. This market movement reflects notable shifts ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

Dublin, May 16, 2025 (GLOBE NEWSWIRE) -- The "Adult Vaccine Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering.

The dynamics of the eosinophilic esophagitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as APT-1011 (Ellodi Pharmaceuticals) ...

Revenue from operations increased 2.57% YoY to Rs 4,259 crore in Q4 FY25. GlaxoSmithKline Pharmaceuticals consolidated net profit jumped 35.17% to Rs 262.87 crore on a 4.79% jump in revenue from ...